Search

Stephen Gucker

Examiner (ID: 445)

Most Active Art Unit
1649
Art Unit(s)
1649, 1647, 1812, 1818, 1646, 1645
Total Applications
799
Issued Applications
370
Pending Applications
114
Abandoned Applications
315

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4302045 [patent_doc_number] => 06326154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Ligand-mediated immunofunctional hormone binding protein assay method' [patent_app_type] => 1 [patent_app_number] => 8/441553 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 21666 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326154.pdf [firstpage_image] =>[orig_patent_app_number] => 441553 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/441553
Ligand-mediated immunofunctional hormone binding protein assay method May 14, 1995 Issued
Array ( [id] => 3939340 [patent_doc_number] => 05981480 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Pantropic neurotrophic factors' [patent_app_type] => 1 [patent_app_number] => 8/441513 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 74 [patent_no_of_words] => 23132 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981480.pdf [firstpage_image] =>[orig_patent_app_number] => 441513 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/441513
Pantropic neurotrophic factors May 14, 1995 Issued
Array ( [id] => 3620242 [patent_doc_number] => 05593844 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Ligand-mediated immunofunctional hormone binding protein assay method' [patent_app_type] => 1 [patent_app_number] => 8/441357 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 21546 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593844.pdf [firstpage_image] =>[orig_patent_app_number] => 441357 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/441357
Ligand-mediated immunofunctional hormone binding protein assay method May 14, 1995 Issued
Array ( [id] => 3879827 [patent_doc_number] => 05728803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Pantropic neurotrophic factors' [patent_app_type] => 1 [patent_app_number] => 8/440049 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 73 [patent_no_of_words] => 21859 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728803.pdf [firstpage_image] =>[orig_patent_app_number] => 440049 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/440049
Pantropic neurotrophic factors May 11, 1995 Issued
08/437612 DNA ENCODING TURKEY HYPOTHALAMIC VASOACTIVE INTESTINAL PIPTIDE May 8, 1995 Abandoned
Array ( [id] => 3661570 [patent_doc_number] => 05624899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Method for using Htk ligand' [patent_app_type] => 1 [patent_app_number] => 8/436044 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 28027 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624899.pdf [firstpage_image] =>[orig_patent_app_number] => 436044 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/436044
Method for using Htk ligand May 4, 1995 Issued
Array ( [id] => 1595230 [patent_doc_number] => 06492177 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Kit for use in treatment of polycystic ovarian disease' [patent_app_type] => B1 [patent_app_number] => 08/436023 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2789 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492177.pdf [firstpage_image] =>[orig_patent_app_number] => 08436023 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/436023
Kit for use in treatment of polycystic ovarian disease May 4, 1995 Issued
Array ( [id] => 3623034 [patent_doc_number] => 05688911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Trk neurotrophin binding motifs' [patent_app_type] => 1 [patent_app_number] => 8/434198 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6087 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688911.pdf [firstpage_image] =>[orig_patent_app_number] => 434198 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/434198
Trk neurotrophin binding motifs May 2, 1995 Issued
Array ( [id] => 3771045 [patent_doc_number] => 05756456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Methods involving sensory and motor neuron derived factor (SMDF)' [patent_app_type] => 1 [patent_app_number] => 8/428927 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 33696 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756456.pdf [firstpage_image] =>[orig_patent_app_number] => 428927 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/428927
Methods involving sensory and motor neuron derived factor (SMDF) Apr 24, 1995 Issued
Array ( [id] => 3868419 [patent_doc_number] => 05763213 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Sensory and motor neuron derived factor (SMDF)' [patent_app_type] => 1 [patent_app_number] => 8/428298 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 33683 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763213.pdf [firstpage_image] =>[orig_patent_app_number] => 428298 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/428298
Sensory and motor neuron derived factor (SMDF) Apr 24, 1995 Issued
Array ( [id] => 3805522 [patent_doc_number] => 05830858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Neurotrophic factor' [patent_app_type] => 1 [patent_app_number] => 8/424826 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18703 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830858.pdf [firstpage_image] =>[orig_patent_app_number] => 424826 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/424826
Neurotrophic factor Apr 18, 1995 Issued
08/426419 NOVEL NEUROTHROPHIC FACTOR Apr 18, 1995 Abandoned
Array ( [id] => 3557013 [patent_doc_number] => 05543498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Peptides to overcome inhibition of nerve growth' [patent_app_type] => 1 [patent_app_number] => 8/417279 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5619 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543498.pdf [firstpage_image] =>[orig_patent_app_number] => 417279 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/417279
Peptides to overcome inhibition of nerve growth Apr 4, 1995 Issued
Array ( [id] => 3627437 [patent_doc_number] => 05621079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Neuropeptide Y receptor' [patent_app_type] => 1 [patent_app_number] => 8/415818 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 13397 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621079.pdf [firstpage_image] =>[orig_patent_app_number] => 415818 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/415818
Neuropeptide Y receptor Apr 2, 1995 Issued
Array ( [id] => 1173221 [patent_doc_number] => 06750196 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Methods of treating disorders of the eye' [patent_app_type] => B1 [patent_app_number] => 08/411295 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 56 [patent_no_of_words] => 15427 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750196.pdf [firstpage_image] =>[orig_patent_app_number] => 08411295 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/411295
Methods of treating disorders of the eye Mar 26, 1995 Issued
08/408094 LIGAND-MEDIATED IMMUNOFUNCTIONAL HORMONE BINDING PROTEIN ASSAY METHOD Mar 20, 1995 Abandoned
Array ( [id] => 3625510 [patent_doc_number] => 05608036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Enhanced secretion of polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/407344 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10335 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608036.pdf [firstpage_image] =>[orig_patent_app_number] => 407344 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/407344
Enhanced secretion of polypeptides Mar 19, 1995 Issued
Array ( [id] => 3948282 [patent_doc_number] => 05955354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'RAS P21-interacting protein (RGL) and its RAS interacting domain (RID)' [patent_app_type] => 1 [patent_app_number] => 8/408519 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 19484 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955354.pdf [firstpage_image] =>[orig_patent_app_number] => 408519 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/408519
RAS P21-interacting protein (RGL) and its RAS interacting domain (RID) Mar 19, 1995 Issued
08/403803 PROSTATE-SPECIFIC MEMBRANE ANTIGEN Mar 16, 1995 Abandoned
Array ( [id] => 3953900 [patent_doc_number] => 05935811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Neuron-restrictive silencer factor nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/398590 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 15996 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935811.pdf [firstpage_image] =>[orig_patent_app_number] => 398590 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/398590
Neuron-restrictive silencer factor nucleic acids Mar 2, 1995 Issued
Menu